In Situ Hybridization, Fluorescence

"In Situ Hybridization, Fluorescence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.

Descriptor ID	D017404
MeSH Number(s)	E01.370.225.500.620.670.325.350 E01.370.225.750.600.670.325.350 E05.200.500.620.670.325.350 E05.200.750.600.670.325.350 E05.393.285.350 E05.393.661.475.350
Concept/Terms	In Situ Hybridization, Fluorescence In Situ Hybridization, Fluorescence Hybridization in Situ, Fluorescent FISH Technique FISH Techniques Technique, FISH Techniques, FISH Fluorescent in Situ Hybridization FISH Technic FISH Technics Technic, FISH Technics, FISH Hybridization in Situ, Fluorescence In Situ Hybridization, Fluorescent

Below are MeSH descriptors whose meaning is more general than "In Situ Hybridization, Fluorescence".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Cytological Techniques [E01.370.225.500]
Histocytological Preparation Techniques [E01.370.225.500.620]
Staining and Labeling [E01.370.225.500.620.670]
In Situ Hybridization [E01.370.225.500.620.670.325]
In Situ Hybridization, Fluorescence [E01.370.225.500.620.670.325.350]
Histological Techniques [E01.370.225.750]
Histocytological Preparation Techniques [E01.370.225.750.600]
Staining and Labeling [E01.370.225.750.600.670]
In Situ Hybridization [E01.370.225.750.600.670.325]
In Situ Hybridization, Fluorescence [E01.370.225.750.600.670.325.350]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Cytological Techniques [E05.200.500]
Histocytological Preparation Techniques [E05.200.500.620]
Staining and Labeling [E05.200.500.620.670]
In Situ Hybridization [E05.200.500.620.670.325]
In Situ Hybridization, Fluorescence [E05.200.500.620.670.325.350]
Histological Techniques [E05.200.750]
Histocytological Preparation Techniques [E05.200.750.600]
Staining and Labeling [E05.200.750.600.670]
In Situ Hybridization [E05.200.750.600.670.325]
In Situ Hybridization, Fluorescence [E05.200.750.600.670.325.350]
Genetic Techniques [E05.393]
Cytogenetic Analysis [E05.393.285]
In Situ Hybridization, Fluorescence [E05.393.285.350]
Nucleic Acid Hybridization [E05.393.661]
In Situ Hybridization [E05.393.661.475]
In Situ Hybridization, Fluorescence [E05.393.661.475.350]

Below are MeSH descriptors whose meaning is related to "In Situ Hybridization, Fluorescence".

Below are MeSH descriptors whose meaning is more specific than "In Situ Hybridization, Fluorescence".

In Situ Hybridization, Fluorescence
Chromosome Painting

publications

Timeline | Most Recent

This graph shows the total number of publications written about "In Situ Hybridization, Fluorescence" by people in this website by year, and whether "In Situ Hybridization, Fluorescence" was a major or minor topic of these publications.

Bar chart showing 83 publications over 21 distinct years, with a maximum of 9 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1997	0	3	3
1999	0	1	1
2002	1	7	8
2003	1	3	4
2004	1	3	4
2005	0	7	7
2006	1	6	7
2007	1	1	2
2008	0	5	5
2009	1	2	3
2010	1	4	5
2011	0	4	4
2012	1	3	4
2013	0	2	2
2014	0	5	5
2015	1	8	9
2016	0	4	4
2017	0	1	1
2018	0	1	1
2019	0	3	3

Below are the most recent publications written about "In Situ Hybridization, Fluorescence" by people in Profiles.

Luo W, Stevens TM, Stafford P, Miettinen M, Gatalica Z, Vranic S. NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review. Curr Oncol. 2021 11 07; 28(6):4485-4503.

View in: PubMed
Kastnerova L, Luzar B, Goto K, Grishakov V, Gatalica Z, Kamarachev J, Martinek P, Hájková V, Grossmann P, Imai H, Fukui H, Michal M, Kazakov DV. Secretory Carcinoma of the Skin: Report of 6 Cases, Including a Case With a Novel NFIX-PKN1 Translocation. Am J Surg Pathol. 2019 08; 43(8):1092-1098.

View in: PubMed
Trindade AJ, Navaneethan U, Aslanian HR, Bhutani MS, Krishnan K, Lichtenstein DR, Melson J, Pannala R, Parsi MA, Schulman AR, Sethi A, Trikudanathan G, Watson RR, Maple JT. Advances in the diagnosis and surveillance of Barrett's esophagus (with videos). Gastrointest Endosc. 2019 09; 90(3):325-334.

View in: PubMed
Somasundaram DB, Aravindan S, Yu Z, Jayaraman M, Tran NTB, Li S, Herman TS, Aravindan N. Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples. BMC Cancer. 2019 Jan 28; 19(1):106.

View in: PubMed
Topcagic J, Feldman R, Ghazalpour A, Swensen J, Gatalica Z, Vranic S. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas. PLoS One. 2018; 13(1):e0191244.

View in: PubMed
Thorne-Nuzzo T, Williams C, Catallini A, Clements J, Singh S, Amberson J, Dickinson K, Gatalica Z, Ho SN, Loftin I, McElhinny A, Towne P. A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib. J Thorac Oncol. 2017 05; 12(5):804-813.

View in: PubMed
Millis SZ, Ikeda S, Reddy S, Gatalica Z, Kurzrock R. Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19?784 Diverse Solid Tumors. JAMA Oncol. 2016 Dec 01; 2(12):1565-1573.

View in: PubMed
Vranic S, Ghosh N, Kimbrough J, Bilalovic N, Bender R, Arguello D, Veloso Y, Dizdarevic A, Gatalica Z. PD-L1 Status in Refractory Lymphomas. PLoS One. 2016; 11(11):e0166266.

View in: PubMed
Garber ST, Hashimoto Y, Weathers SP, Xiu J, Gatalica Z, Verhaak RG, Zhou S, Fuller GN, Khasraw M, de Groot J, Reddy SK, Spetzler D, Heimberger AB. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol. 2016 10; 18(10):1357-66.

View in: PubMed
Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, Li S, Koelsch KA, Igoe A, Talsania M, Kumar J, Maier-Moore JS, Harris VM, Gopalakrishnan R, Jonsson R, Lessard JA, Lu X, Gottenberg JE, Anaya JM, Cunninghame-Graham DS, Huang AJW, Brennan MT, Hughes P, Illei GG, Miceli-Richard C, Keystone EC, Bykerk VP, Hirschfield G, Xie G, Ng WF, Nordmark G, Eriksson P, Omdal R, Rhodus NL, Rischmueller M, Rohrer M, Segal BM, Vyse TJ, Wahren-Herlenius M, Witte T, Pons-Estel B, Alarcon-Riquelme ME, Guthridge JM, James JA, Lessard CJ, Kelly JA, Thompson SD, Gaffney PM, Montgomery CG, Edberg JC, Kimberly RP, Alarcón GS, Langefeld CL, Gilkeson GS, Kamen DL, Tsao BP, McCune WJ, Salmon JE, Merrill JT, Weisman MH, Wallace DJ, Utset TO, Bottinger EP, Amos CI, Siminovitch KA, Mariette X, Sivils KL, Harley JB, Scofield RH. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis Rheumatol. 2016 05; 68(5):1290-1300.

View in: PubMed

People

Explore

Similar Concepts

Top Journals